Tim Dirks
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tim Dirks has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Julia Elisabeth Bandow
Ruhr University Bochum
8 shared publications - Frank Hollmann
Delft University of Technology
6 shared publications - Abdulkadir Yayci
Faculty of Biology and Biotechnology, Ruhr University Bochum, Universitätsstr. 150, Bochum, Germany, 44801
4 shared publications Davina Stoesser
Applied Microbiology, Faculty of Biology and Biotechnology Ruhr University Bochum Bochum Germany
4 shared publications- Judith Golda
Plasma Interface Physics, Ruhr University Bochum, Bochum, Germany
3 shared publications - Marco Krewing
Ruhr University Bochum
3 shared publications
Latest Publications
- Open Access
- 30 August 2026
- Published by Wiley in ChemCatChem
- Vol. 18 (17) , e71023
Nanosecond Pulsed Microwave Plasma Torch for Continuous In‐Line H 2 O 2 Supply: A Path to Stable and Scalable Plasma‐Driven Biocatalysis
Plasma‐driven H 2 O 2 generation offers a potential sustainable route for biotransformations, but its application is hindered by challenges such as insufficient H 2 O 2 production and enzyme degradation. This study establishes plasma‐driven biocatalysis using a nanosecond pulsed microwave plasma torch (npMWPT), highlighting its unique advantages over previously applied sources. npMWPT‐driven biocatalysis addresses insufficient plasma‐generated H 2 O 2 production by enabling continuous H 2 O 2 supply while decoupling plasma treatment from enzymatic reactions. We investigated the effectiveness of npMWPT‐driven biocatalysis using both immobilized and free recombinant unspecific peroxygenase from Agrocybe aegerita (r Aae UPO) to convert ABTS and ethylbenzene. For ABTS, immobilized r Aae UPO demonstrated reusability across five reaction cycles (turnover number TON 44,637 µmol ABTS* µmoL −1 r Aae UPO ). The decoupling of npMWPT‐based H 2 O 2 production resulted in a TON of 66,495 µmol ( R )‐1‐PhOl µmoL −1 r Aae UPO with ethylbenzene for free r Aae UPO, outperforming the use of immobilized r Aae UPO for the first time in plasma‐driven biocatalysis (TTN 22,116). Mixing optimization improved conversion rates, while observed enzyme inactivation under continuous operation revealed that H 2 O 2 generation exceeded enzymatic consumption under the investigated conditions. The present study identifies supply‐demand matching as the key optimization target for npMWPT‐driven biocatalysis. This proof‐of‐principle work demonstrates the successful integration of spatially decoupled npMWPT H 2 O 2 generation with peroxygenase‐based biocatalysis and provides a basis for future process‐controlled plasma‐driven biocatalysis.
- 30 August 2026
- Published by Wiley in ChemCatChem
- Vol. 18 (17) , e71023
Open AccessNanosecond Pulsed Microwave Plasma Torch for Continuous In‐Line H 2 O 2 Supply: A Path to Stable and Scalable Plasma‐Driven Biocatalysis
Plasma‐driven H 2 O 2 generation offers a potential sustainable route for biotransformations, but its application is hindered by challenges such as insufficient H 2 O 2 production and enzyme degradation. This study establishes plasma‐driven biocatalysis using a nanosecond pulsed microwave plasma torch (npMWPT), highlighting its unique advantages over previously applied sources. npMWPT‐driven biocatalysis addresses insufficient plasma‐generated H 2 O 2 production by enabling continuous H 2 O 2 supply while decoupling plasma treatment from enzymatic reactions. We investigated the effectiveness of npMWPT‐driven biocatalysis using both immobilized and free recombinant unspecific peroxygenase from Agrocybe aegerita (r Aae UPO) to convert ABTS and ethylbenzene. For ABTS, immobilized r Aae UPO demonstrated reusability across five reaction cycles (turnover number TON 44,637 µmol ABTS* µmoL −1 r Aae UPO ). The decoupling of npMWPT‐based H 2 O 2 production resulted in a TON of 66,495 µmol ( R )‐1‐PhOl µmoL −1 r Aae UPO with ethylbenzene for free r Aae UPO, outperforming the use of immobilized r Aae UPO for the first time in plasma‐driven biocatalysis (TTN 22,116). Mixing optimization improved conversion rates, while observed enzyme inactivation under continuous operation revealed that H 2 O 2 generation exceeded enzymatic consumption under the investigated conditions. The present study identifies supply‐demand matching as the key optimization target for npMWPT‐driven biocatalysis. This proof‐of‐principle work demonstrates the successful integration of spatially decoupled npMWPT H 2 O 2 generation with peroxygenase‐based biocatalysis and provides a basis for future process‐controlled plasma‐driven biocatalysis.
- Open Access
- 22 June 2025
- Published by Wiley in ChemistryOpen
- Vol. 14 (9) , e2500057
The Atmospheric Pressure Capillary Plasma Jet Is Well‐Suited to Supply H 2 O 2 for Plasma‐Driven Biocatalysis
Plasma‐generated H 2 O 2 can be used to fuel biocatalytic reactions that require H 2 O 2 as a cosubstrate, such as the conversion of ethylbenzene to ( R )‐1‐phenylethanol (( R )‐1‐PhOl) catalyzed by unspecific peroxygenase from Agrocybe aegerita (r Aae UPO). Immobilization is recently shown to protect biocatalysts from inactivation by highly reactive plasma‐produced species; however, H 2 O 2 supply by the employed plasma sources (μAPPJ and DBD) is limiting for r Aae UPO performance. This study evaluates a recently introduced capillary plasma jet for suitability to supply H 2 O 2 in situ. H 2 O 2 production is modulated by varying the water concentration in the feed gas, providing a greater operating window for applications in plasma‐driven biocatalysis. In a static system after 80 min of biocatalysis, a turnover number of 44,199 mol ( R )‐1‐PhOl mol −1 r Aae UPO is achieved without significant enzyme inactivation. By exchanging the reaction solution every 5 min, a total product yield of 122 μmol ( R )‐1‐PhOl is achieved in 700 min run time, resulting in a total turnover number of 174,209 mol ( R )‐1‐PhOl mol −1 r Aae UPO . This study concludes that the capillary plasma jet, due to its flexibility regarding feed gas, admixtures, and power input, is well suited for in situ H 2 O 2 generation for plasma‐driven biocatalysis tailoring to enzymes with high H 2 O 2 turnover.
- 22 June 2025
- Published by Wiley in ChemistryOpen
- Vol. 14 (9) , e2500057
Open AccessThe Atmospheric Pressure Capillary Plasma Jet Is Well‐Suited to Supply H 2 O 2 for Plasma‐Driven Biocatalysis
Plasma‐generated H 2 O 2 can be used to fuel biocatalytic reactions that require H 2 O 2 as a cosubstrate, such as the conversion of ethylbenzene to ( R )‐1‐phenylethanol (( R )‐1‐PhOl) catalyzed by unspecific peroxygenase from Agrocybe aegerita (r Aae UPO). Immobilization is recently shown to protect biocatalysts from inactivation by highly reactive plasma‐produced species; however, H 2 O 2 supply by the employed plasma sources (μAPPJ and DBD) is limiting for r Aae UPO performance. This study evaluates a recently introduced capillary plasma jet for suitability to supply H 2 O 2 in situ. H 2 O 2 production is modulated by varying the water concentration in the feed gas, providing a greater operating window for applications in plasma‐driven biocatalysis. In a static system after 80 min of biocatalysis, a turnover number of 44,199 mol ( R )‐1‐PhOl mol −1 r Aae UPO is achieved without significant enzyme inactivation. By exchanging the reaction solution every 5 min, a total product yield of 122 μmol ( R )‐1‐PhOl is achieved in 700 min run time, resulting in a total turnover number of 174,209 mol ( R )‐1‐PhOl mol −1 r Aae UPO . This study concludes that the capillary plasma jet, due to its flexibility regarding feed gas, admixtures, and power input, is well suited for in situ H 2 O 2 generation for plasma‐driven biocatalysis tailoring to enzymes with high H 2 O 2 turnover.
- Open Access
Plasma-driven biocatalysis using the cytochrome P450 enzyme CYP152 BSβ
Plasma-driven biocatalysis utilizes in situ H 2 O 2 production by atmospheric pressure plasmas to drive H 2 O 2 -dependent enzymatic reactions. Having previously established plasma-driven biocatalysis using recombinant unspecific peroxygenase from Agrocybe aegerita (r Aae UPO) to produce ( R )-1-phenylethanol from ethylbenzene (ETBE), we here employed CYP152 from Bacillus subtilis (CYP152 BSβ ). CYP152 BSβ naturally hydroxylates medium and long-chain carboxylic acids, and, with short-chain carboxylic acids as decoy molecules, also converts non-natural substrates such as ETBE. To produce active CYP152 BSβ overexpression and heme loading were optimized. The conversion of the non-natural substrates guaiacol and ABTS with heptanoic acid as decoy molecule and H 2 O 2 from stock solution yielded 18.28 and 21.13 nmol product min -1 , respectively. These reactions also served to assess compatibility of CYP152 BSβ with plasma-driven biocatalysis regarding temperature and H 2 O 2 operating windows. To establish CYP152 BSβ -based plasma-driven biocatalysis, immobilized enzyme in a rotating bed reactor (5 ml reaction volume) was then supplied with H 2 O 2 from a capillary plasma jet operated with 1280 ppm H 2 O in helium. After a 120 min run time a turnover number (TON) of 18.82 mol ( R )-1-PhOl was reached. We conclude that plasma-driven biocatalysis can be extended to other H 2 O 2 -dependent enzymes. Future efforts will be directed at increasing the TON and product range.
Open AccessPlasma-driven biocatalysis using the cytochrome P450 enzyme CYP152 BSβ
Plasma-driven biocatalysis utilizes in situ H 2 O 2 production by atmospheric pressure plasmas to drive H 2 O 2 -dependent enzymatic reactions. Having previously established plasma-driven biocatalysis using recombinant unspecific peroxygenase from Agrocybe aegerita (r Aae UPO) to produce ( R )-1-phenylethanol from ethylbenzene (ETBE), we here employed CYP152 from Bacillus subtilis (CYP152 BSβ ). CYP152 BSβ naturally hydroxylates medium and long-chain carboxylic acids, and, with short-chain carboxylic acids as decoy molecules, also converts non-natural substrates such as ETBE. To produce active CYP152 BSβ overexpression and heme loading were optimized. The conversion of the non-natural substrates guaiacol and ABTS with heptanoic acid as decoy molecule and H 2 O 2 from stock solution yielded 18.28 and 21.13 nmol product min -1 , respectively. These reactions also served to assess compatibility of CYP152 BSβ with plasma-driven biocatalysis regarding temperature and H 2 O 2 operating windows. To establish CYP152 BSβ -based plasma-driven biocatalysis, immobilized enzyme in a rotating bed reactor (5 ml reaction volume) was then supplied with H 2 O 2 from a capillary plasma jet operated with 1280 ppm H 2 O in helium. After a 120 min run time a turnover number (TON) of 18.82 mol ( R )-1-PhOl was reached. We conclude that plasma-driven biocatalysis can be extended to other H 2 O 2 -dependent enzymes. Future efforts will be directed at increasing the TON and product range.
- Open Access
Iron-sulfur cluster proteins present the weak spot in plasma-treated Escherichia coli
Non-thermal atmospheric pressure plasmas have an antiseptic activity beneficial in different medical applications. In a genome-wide screening, hydrogen peroxide and superoxide were identified as key species contributing to the antibacterial effects of plasma while [FeS] cluster proteins emerged as potential cellular targets. We investigated the impact of plasma treatment on [FeS] cluster homeostasis in Escherichia coli treated for 1 min with the effluent of a microscale atmospheric pressure plasma jet (μAPPJ). Mutants defective in [FeS] cluster synthesis and maintenance lacking the SufBC2D scaffold protein complex or desulfurase IscS were hypersensitive to plasma treatment. Monitoring the activity of [FeS] cluster proteins of the tricarboxylic acid cycle (aconitase, fumarase, succinate dehydrogenase) and malate dehydrogenase (no [FeS] clusters), we identified cysteine, iron, superoxide dismutase, and catalase as determinants of plasma sensitivity. Survival rates, enzyme activity, and restoration of enzyme activity after plasma treatment were superior in mutants with elevated cysteine levels and in the wildtype under iron replete conditions. Mutants with elevated hydrogen peroxide and superoxide detoxification capacity over-expressing sodA and katE showed full protection from plasma-induced enzyme inactivation and survival rates increased from 34% (controls) to 87%. Our study indicates that metabolic and genetic adaptation of bacteria may result in plasma tolerance and resistance, respectively.
Open AccessIron-sulfur cluster proteins present the weak spot in plasma-treated Escherichia coli
Non-thermal atmospheric pressure plasmas have an antiseptic activity beneficial in different medical applications. In a genome-wide screening, hydrogen peroxide and superoxide were identified as key species contributing to the antibacterial effects of plasma while [FeS] cluster proteins emerged as potential cellular targets. We investigated the impact of plasma treatment on [FeS] cluster homeostasis in Escherichia coli treated for 1 min with the effluent of a microscale atmospheric pressure plasma jet (μAPPJ). Mutants defective in [FeS] cluster synthesis and maintenance lacking the SufBC2D scaffold protein complex or desulfurase IscS were hypersensitive to plasma treatment. Monitoring the activity of [FeS] cluster proteins of the tricarboxylic acid cycle (aconitase, fumarase, succinate dehydrogenase) and malate dehydrogenase (no [FeS] clusters), we identified cysteine, iron, superoxide dismutase, and catalase as determinants of plasma sensitivity. Survival rates, enzyme activity, and restoration of enzyme activity after plasma treatment were superior in mutants with elevated cysteine levels and in the wildtype under iron replete conditions. Mutants with elevated hydrogen peroxide and superoxide detoxification capacity over-expressing sodA and katE showed full protection from plasma-induced enzyme inactivation and survival rates increased from 34% (controls) to 87%. Our study indicates that metabolic and genetic adaptation of bacteria may result in plasma tolerance and resistance, respectively.
- Open Access
The atmospheric pressure capillary plasma jet is well-suited to supply H 2 O 2 for plasma-driven biocatalysis
Plasma-generated H 2 O 2 can be used to fuel biocatalytic reactions that require H 2 O 2 as co-substrate such as the conversion of ethylbenzene to ( R )-1-phenylethanol (( R )-1-PhOl) catalyzed by unspecific peroxygenase from Agrocybe aegerita (r Aae UPO). Immobilization was recently shown to protect biocatalysts from inactivation by highly reactive plasma-produced species, however, H 2 O 2 supply by the employed plasma sources (µAPPJ and DBD) was limiting for r Aae UPO performance. In this study we evaluated a recently introduced capillary plasma jet for suitability to supply H 2 O 2 in situ . H 2 O 2 production was modulated by varying the water concentration in the feed gas, providing a greater operating window for applications in plasma-driven biocatalysis. In a static system after 80 min of biocatalysis, a turnover number of 44,199 mol ( R )-1-PhOl mol -1 r Aae UPO was achieved without significant enzyme inactivation. By exchanging the reaction solution every 5 min, a total product yield of 122 µmol ( R )-1-PhOl was achieved in 700 min run time, resulting in a total turnover number of 174,209 mol ( R )-1-PhOl mol -1 r Aae UPO . We conclude that the capillary plasma jet, due to its flexibility regarding feed gas, admixtures, and power input, is well-suited for in situ H 2 O 2 generation for plasma-driven biocatalysis tailoring to enzymes with high H 2 O 2 turnover.
Open AccessThe atmospheric pressure capillary plasma jet is well-suited to supply H 2 O 2 for plasma-driven biocatalysis
Plasma-generated H 2 O 2 can be used to fuel biocatalytic reactions that require H 2 O 2 as co-substrate such as the conversion of ethylbenzene to ( R )-1-phenylethanol (( R )-1-PhOl) catalyzed by unspecific peroxygenase from Agrocybe aegerita (r Aae UPO). Immobilization was recently shown to protect biocatalysts from inactivation by highly reactive plasma-produced species, however, H 2 O 2 supply by the employed plasma sources (µAPPJ and DBD) was limiting for r Aae UPO performance. In this study we evaluated a recently introduced capillary plasma jet for suitability to supply H 2 O 2 in situ . H 2 O 2 production was modulated by varying the water concentration in the feed gas, providing a greater operating window for applications in plasma-driven biocatalysis. In a static system after 80 min of biocatalysis, a turnover number of 44,199 mol ( R )-1-PhOl mol -1 r Aae UPO was achieved without significant enzyme inactivation. By exchanging the reaction solution every 5 min, a total product yield of 122 µmol ( R )-1-PhOl was achieved in 700 min run time, resulting in a total turnover number of 174,209 mol ( R )-1-PhOl mol -1 r Aae UPO . We conclude that the capillary plasma jet, due to its flexibility regarding feed gas, admixtures, and power input, is well-suited for in situ H 2 O 2 generation for plasma-driven biocatalysis tailoring to enzymes with high H 2 O 2 turnover.
- Open Access
- 25 October 2023
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 20 (207) , 20230300
The cold atmospheric pressure plasma-generated species superoxide, singlet oxygen and atomic oxygen activate the molecular chaperone Hsp33
Cold atmospheric pressure plasmas are used for surface decontamination or disinfection, e.g. in clinical settings. Protein aggregation has been shown to significantly contribute to the antibacterial mechanisms of plasma. To investigate the potential role of the redox-activated zinc-binding chaperone Hsp33 in preventing protein aggregation and thus mediating plasma resistance, we compared the plasma sensitivity of wild-type E. coli to that of an hslO deletion mutant lacking Hsp33 as well as an over-producing strain. Over-production of Hsp33 increased plasma survival rates above wild-type levels. Hsp33 was previously shown to be activated by plasma in vitro . For the PlasmaDerm source applied in dermatology, reversible activation of Hsp33 was confirmed. Thiol oxidation and Hsp33 unfolding, both crucial for Hsp33 activation, occurred during plasma treatment. After prolonged plasma exposure, however, unspecific protein oxidation was detected, the ability of Hsp33 to bind zinc ions was decreased without direct modifications of the zinc-binding motif, and the protein was inactivated. To identify chemical species of potential relevance for plasma-induced Hsp33 activation, reactive oxygen species were tested for their ability to activate Hsp33 in vitro . Superoxide, singlet oxygen and potentially atomic oxygen activate Hsp33, while no evidence was found for activation by ozone, peroxynitrite or hydroxyl radicals.
- 25 October 2023
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 20 (207) , 20230300
Open AccessThe cold atmospheric pressure plasma-generated species superoxide, singlet oxygen and atomic oxygen activate the molecular chaperone Hsp33
Cold atmospheric pressure plasmas are used for surface decontamination or disinfection, e.g. in clinical settings. Protein aggregation has been shown to significantly contribute to the antibacterial mechanisms of plasma. To investigate the potential role of the redox-activated zinc-binding chaperone Hsp33 in preventing protein aggregation and thus mediating plasma resistance, we compared the plasma sensitivity of wild-type E. coli to that of an hslO deletion mutant lacking Hsp33 as well as an over-producing strain. Over-production of Hsp33 increased plasma survival rates above wild-type levels. Hsp33 was previously shown to be activated by plasma in vitro . For the PlasmaDerm source applied in dermatology, reversible activation of Hsp33 was confirmed. Thiol oxidation and Hsp33 unfolding, both crucial for Hsp33 activation, occurred during plasma treatment. After prolonged plasma exposure, however, unspecific protein oxidation was detected, the ability of Hsp33 to bind zinc ions was decreased without direct modifications of the zinc-binding motif, and the protein was inactivated. To identify chemical species of potential relevance for plasma-induced Hsp33 activation, reactive oxygen species were tested for their ability to activate Hsp33 in vitro . Superoxide, singlet oxygen and potentially atomic oxygen activate Hsp33, while no evidence was found for activation by ozone, peroxynitrite or hydroxyl radicals.
- Open Access
- 25 October 2023
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 20 (207) , 20230299
Immobilization protects enzymes from plasma-mediated inactivation
Non-thermal plasmas are used in various applications to inactivate biological agents or biomolecules. A complex cocktail of reactive species, (vacuum) UV radiation and in some cases exposure to an electric field together cause the detrimental effects. In contrast to this disruptive property of technical plasmas, we have shown previously that it is possible to use non-thermal plasma-generated species such as H 2 O 2 as cosubstrates in biocatalytic reactions. One of the main limitations in plasma-driven biocatalysis is the relatively short enzyme lifetime under plasma-operating conditions. This challenge could be overcome by immobilizing the enzymes on inert carrier materials. Here, we tested whether immobilization is suited to protect proteins from inactivation by plasma. To this end, using a dielectric barrier discharge device (PlasmaDerm), plasma stability was tested for five enzymes immobilized on ten different carrier materials. A comparative analysis of the treatment times needed to reduce enzyme activity of immobilized and free enzyme by 30% showed a maximum increase by a factor of 44. Covalent immobilization on a partly hydrophobic carrier surface proved most effective. We conclude from the study, that immobilization universally protects enzymes under plasma-operating conditions, paving the way for new emerging applications.
- 25 October 2023
- Published by The Royal Society in Journal of The Royal Society Interface
- Vol. 20 (207) , 20230299
Open AccessImmobilization protects enzymes from plasma-mediated inactivation
Non-thermal plasmas are used in various applications to inactivate biological agents or biomolecules. A complex cocktail of reactive species, (vacuum) UV radiation and in some cases exposure to an electric field together cause the detrimental effects. In contrast to this disruptive property of technical plasmas, we have shown previously that it is possible to use non-thermal plasma-generated species such as H 2 O 2 as cosubstrates in biocatalytic reactions. One of the main limitations in plasma-driven biocatalysis is the relatively short enzyme lifetime under plasma-operating conditions. This challenge could be overcome by immobilizing the enzymes on inert carrier materials. Here, we tested whether immobilization is suited to protect proteins from inactivation by plasma. To this end, using a dielectric barrier discharge device (PlasmaDerm), plasma stability was tested for five enzymes immobilized on ten different carrier materials. A comparative analysis of the treatment times needed to reduce enzyme activity of immobilized and free enzyme by 30% showed a maximum increase by a factor of 44. Covalent immobilization on a partly hydrophobic carrier surface proved most effective. We conclude from the study, that immobilization universally protects enzymes under plasma-operating conditions, paving the way for new emerging applications.
- 28 October 2020
- Published by IOP Publishing in Journal of Physics D: Applied Physics
- Vol. 54 (3) , 035204
Protection strategies for biocatalytic proteins under plasma treatment
In plasma-driven biocatalysis, enzymes are employed to carry out reactions using species generated by non-thermal plasmas as the precursors. We have previously demonstrated that this is feasible in principle, but that the approach suffers from the short lifetime of the biocatalyst under operating conditions. In this work, protection strategies were investigated to prevent the dielectric barrier discharge plasma-induced inactivation of biocatalysts, using recombinant unspecific peroxygenase from Agrocybe aegerita ( r Aae UPO), one of the most promising enzymes for plasma-driven biocatalysis. Treatment in oxygen-free atmospheres did not provide any advantage over treatment in synthetic air, indicating that the detrimental reactive species did not originate from oxygen in the plasma phase. Chemical scavengers were employed to eliminate undesired reactive species, without any long-term effect on enzyme lifetime. Similarly, chaperones, including the known stress response proteins Hsp33, CnoX, and RidA did not increase the lifetime of r Aae UPO. Immobilization of the biocatalyst proved effective in preserving enzyme activity. The residual activity of r Aae UPO after plasma treatment strongly depended on the specific immobilization support. Essentially complete protection for at least 15 min of plasma exposure was achieved with an epoxy-butyl-functionalized carrier. This study presents new insights into plasma–protein interactions and plots a path forward for protecting biocatalytic proteins from plasma-mediated inactivation.
- 28 October 2020
- Published by IOP Publishing in Journal of Physics D: Applied Physics
- Vol. 54 (3) , 035204
Protection strategies for biocatalytic proteins under plasma treatment
In plasma-driven biocatalysis, enzymes are employed to carry out reactions using species generated by non-thermal plasmas as the precursors. We have previously demonstrated that this is feasible in principle, but that the approach suffers from the short lifetime of the biocatalyst under operating conditions. In this work, protection strategies were investigated to prevent the dielectric barrier discharge plasma-induced inactivation of biocatalysts, using recombinant unspecific peroxygenase from Agrocybe aegerita ( r Aae UPO), one of the most promising enzymes for plasma-driven biocatalysis. Treatment in oxygen-free atmospheres did not provide any advantage over treatment in synthetic air, indicating that the detrimental reactive species did not originate from oxygen in the plasma phase. Chemical scavengers were employed to eliminate undesired reactive species, without any long-term effect on enzyme lifetime. Similarly, chaperones, including the known stress response proteins Hsp33, CnoX, and RidA did not increase the lifetime of r Aae UPO. Immobilization of the biocatalyst proved effective in preserving enzyme activity. The residual activity of r Aae UPO after plasma treatment strongly depended on the specific immobilization support. Essentially complete protection for at least 15 min of plasma exposure was achieved with an epoxy-butyl-functionalized carrier. This study presents new insights into plasma–protein interactions and plots a path forward for protecting biocatalytic proteins from plasma-mediated inactivation.
- Open Access
- 27 August 2020
- Published by Wiley in ChemCatChem
- Vol. 12 (23) , 5893-5897
Microscale Atmospheric Pressure Plasma Jet as a Source for Plasma‐Driven Biocatalysis
The use of a microscale atmospheric pressure plasma jet (μAPPJ) was investigated for its potential to supply hydrogen peroxide in biocatalysis. Compared to a previously employed dielectric barrier discharge (DBD), the μAPPJ offered significantly higher H2O2 production rates and better handling of larger reaction volumes. The performance of the μAPPJ was evaluated with recombinant unspecific peroxygenase from Agrocybe aegerita (rAaeUPO). Using plasma‐treated buffer, no side reactions with other plasma‐generated species were detected. For long‐term treatment, rAaeUPO was immobilized, transferred to a rotating bed reactor, and reactions performed using the μAPPJ. The enzyme had a turnover of 36,415 mol mol−1 and retained almost full activity even after prolonged plasma treatment. Overall, the μAPPJ presents a promising plasma source for plasma‐driven biocatalysis.
- 27 August 2020
- Published by Wiley in ChemCatChem
- Vol. 12 (23) , 5893-5897
Open AccessMicroscale Atmospheric Pressure Plasma Jet as a Source for Plasma‐Driven Biocatalysis
The use of a microscale atmospheric pressure plasma jet (μAPPJ) was investigated for its potential to supply hydrogen peroxide in biocatalysis. Compared to a previously employed dielectric barrier discharge (DBD), the μAPPJ offered significantly higher H2O2 production rates and better handling of larger reaction volumes. The performance of the μAPPJ was evaluated with recombinant unspecific peroxygenase from Agrocybe aegerita (rAaeUPO). Using plasma‐treated buffer, no side reactions with other plasma‐generated species were detected. For long‐term treatment, rAaeUPO was immobilized, transferred to a rotating bed reactor, and reactions performed using the μAPPJ. The enzyme had a turnover of 36,415 mol mol−1 and retained almost full activity even after prolonged plasma treatment. Overall, the μAPPJ presents a promising plasma source for plasma‐driven biocatalysis.